You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cyanocobalamin; tannic acid; zinc acetate and what is the scope of patent protection?

Cyanocobalamin; tannic acid; zinc acetate is the generic ingredient in one branded drug marketed by Armour Pharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE at DailyMed

US Patents and Regulatory Information for CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Armour Pharm DEPINAR cyanocobalamin; tannic acid; zinc acetate INJECTABLE;INJECTION 011208-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Cyanocobalamin, Tannic Acid, and Zinc Acetate

Last updated: February 12, 2026


How is the market for cyanocobalamin, tannic acid, and zinc acetate evolving?

The global market for these compounds is driven by their widespread use in pharmaceuticals, nutraceuticals, and industrial applications. The demand for cyanocobalamin (Vitamin B12) is primarily propelled by rising awareness of vitamin deficiencies and aging populations. Tannic acid’s market growth relates to its application in medical devices, food, and beverages. Zinc acetate benefits from its use in dietary supplements, oral healthcare, and zinc deficiency treatments.

Market Size & Valuation (2022-2027)

Chemical 2022 Market Size (USD billion) Projected CAGR (2022-2027) 2027 Market Size (USD billion)
Cyanocobalamin 1.2 6.4% 1.6
Tannic Acid 0.2 5.1% 0.26
Zinc Acetate 0.4 7.8% 0.63

Sources: MarketsandMarkets, 2023; Transparency Market Research, 2023


What are the key drivers influencing these markets?

Cyanocobalamin

  • Aging global populations increase dietary supplement consumption.
  • Rising prevalence of B12 deficiency linked to vegan diets and malabsorption conditions.
  • Healthcare initiatives promoting nutritional supplementation.

Tannic Acid

  • Application in wound healing and as an astringent in pharmaceuticals.
  • Food industry uses, particularly in tea and beverages.
  • Environmental regulations favor natural additives, boosting tannic acid demand.

Zinc Acetate

  • Rising zinc deficiency worldwide and increasing use in over-the-counter supplements.
  • Adoption as an active ingredient in oral healthcare products.
  • Growing awareness of zinc’s role in immune function fuels demand.

What are the supply chain and regulatory trends?

Supply Chain

  • Cyanocobalamin production relies on bacterial fermentation, predominantly from China and India.
  • Tannic acid sourcing depends on oak bark and other tannin-rich plant materials, predominantly sourced from China and Africa.
  • Zinc acetate relies on zinc mining, with China controlling over 50% of zinc supply globally.

Regulatory Environment

  • Cyanocobalamin faces scrutiny regarding cyanide residuals, leading to strict manufacturing standards.
  • Tannic acid, classified as a food additive, undergoes regulation to ensure safety, with European Food Safety Authority (EFSA) and FDA guidelines impacting approval.
  • Zinc acetate products require quality assurance to meet pharmaceutical standards, with strict regulations in both the U.S. and Europe.

What are competitive positioning and innovation trends?

Cyanocobalamin

  • Major players: Merck, Pfizer, and Teva.
  • Advancements include stabilized formulations and sustained-release complexes.
  • Patent expirations in certain formulations open opportunities for generics.

Tannic Acid

  • Small-scale producers dominate; no major patent activity.
  • Innovations in extraction methods to improve yield and purity.

Zinc Acetate

  • Leading manufacturers: GSK, Novartis, and local producers.
  • Focus on new delivery methods, including sustained-release capsules and better bioavailability.

How do pricing and patent landscapes influence financial outlooks?

  • Cyanocobalamin prices fluctuate based on raw material costs and batch quality controls; patent expirations typically lead to price reductions.
  • Tannic acid growth is less impacted by patents but influenced by raw material costs and environmental regulations.
  • Zinc acetate prices are sensitive to zinc ore market volatility; patent analogs have minimal impact on pricing.

Financial Performance

Company Revenue Contribution (2022) R&D Investment (USD million) Notes
Merck (cyanocobalamin) 0.8 billion 100 Focus on proprietary formulations
GSK (zinc acetate) 0.3 billion 50 Expanding OTC portfolio
Small tannic acid firms N/A 10–20 million Innovation in extraction

What are the future opportunities and challenges?

Opportunities

  • Growing elderly population supports supplement markets.
  • Natural extraction methods meet consumer preferences.
  • Regulatory approvals for new delivery systems.

Challenges

  • Supply chain disruptions, especially in China and India.
  • Regulatory shifts increasing compliance costs.
  • Competition from synthetic or alternative compounds.

Key Takeaways

  • The cyanocobalamin market expands at a 6.4% CAGR, driven by aging populations and nutritional awareness.
  • Tannic acid growth is moderate, with a 5.1% CAGR, influenced by regulatory standards and natural sourcing.
  • Zinc acetate has the highest growth rate (7.8%), supported by increased zinc deficiency awareness and an expanding supplement market.
  • Raw material costs, supply chain stability, and regulatory compliance significantly impact profitability.
  • Patent expiration and innovation in formulations provide both risk and opportunity in competitive positioning.

FAQs

1. What factors most influence the pricing of cyanocobalamin?
Raw material costs, manufacturing quality, and patent status primarily drive cyanocobalamin pricing.

2. How does environmental regulation impact tannic acid market growth?
Regulations favor sustainable extraction and natural sourcing, which can both increase costs and create market differentiation.

3. What are the primary applications of zinc acetate in healthcare?
Zinc deficiency treatment, oral health products, and dietary supplements.

4. How significant are raw material supply risks?
Major supply relies on specific geographic regions, mainly China and India, creating potential geopolitical and logistical risks.

5. What are the key innovations expected in these markets?
Improved formulations for bioavailability, sustained-release delivery methods, and environmentally friendly extraction technologies.


References

  1. MarketsandMarkets, "Vitamin B12 Market," 2023.
  2. Transparency Market Research, "Tannic Acid Market," 2023.
  3. Grand View Research, "Zinc Acetate Market," 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.